Quintet Private Bank (Europe)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Quintet Private Bank (Europe)'s PFE Position: Q2 2026 in Review
Quintet Private Bank (Europe) reduced its Pfizer (PFE) stake by 2.2% in Q2 2026, selling an estimated $280K and leaving 486,935 shares worth $11.7M. The position accounts for 0.73% of the portfolio, ranked #33.
Quintet Private Bank (Europe) first reported a position in PFE in Q2 2022 and has held it in 15 quarters since. The position peaked at $15.2M in Q3 2023. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Quintet Private Bank (Europe) held 486,935 shares of Pfizer worth $11.7M as of Q2 2026.
- Quintet Private Bank (Europe) sold 10,713 Pfizer shares in Q2 2026, an estimated $280K.
- Pfizer made up 0.73% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #33 holding.
- Quintet Private Bank (Europe) first reported a position in Pfizer in Q2 2022 and has held it in 15 quarters since.
- Quintet Private Bank (Europe)'s Pfizer position peaked at $15.2M in Q3 2023.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.